Sort
16,300 grants matching “fatty liver disease”
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity
$666,806Jonathan Q. Purnell · Oregon Health & Science University · R01 · FY2016 · DK
Role of Fatty Acid Oxidation Defects in Insulin Sensitivity
$666,806Jonathan Q. Purnell · Oregon Health & Science University · R01 · FY2017 · DK
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD
$666,621Claude B Sirlin · University Of California, San Diego · R01 · FY2018 · DK
Longitudinal Study of Early NAFLD Progression and the Gut Microbiome in Asian Americans, Native Hawaiians and Whites
$666,558Unhee Lim · University Of Hawaii At Manoa · R01 · FY2024 · MD
Development of Oral Small Molecule PCSK9 Antagonist
$666,558Nabil A Elshourbagy · Shifa Biomedical Corporation · R44 · FY2018 · HL
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease
$666,411Christopher B Newgard · Duke University · R01 · FY2020 · DK
Adipose Mitochondial Quality Control and Cardiovascular Function in Metabolically Healthy and Unhealthy Obese Monkeys
$666,352Kylie Kavanagh · Wake Forest University Health Sciences · R01 · FY2022 · HL
Symptom Distress Mechanisms in Digestive Disorders
$666,334Wendy Henderson · National Institute Of Nursing Research · ZIA · FY2018 · NR
Identification and functional impact of NAFLD associated genetic variants
$666,079Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2017 · DK
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH)
$665,909Lindsay Tara Fourman · Massachusetts General Hospital · R01 · FY2025 · AG
Neuroimaging predictors of bariatric surgical outcomes
$665,405Pavlos Papasavas · Hartford Hospital · R01 · FY2019 · DK
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD
$665,303Claude B Sirlin · University Of California, San Diego · R01 · FY2017 · DK
Role of liver and visceral fat in glucose and lipid metabolism during pregnancy
$665,049Kimberly Kristine Vesco · Kaiser Foundation Research Institute · R01 · FY2016 · DK
Dissecting the Intracellular and Extracellular Role of TREM2 in the Pathogenesis of Non-Alcoholic Steatohepatitis.
$665,028Debanjan Dhar · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · DK
Living Cell Arrays for Real Time Functional Genomics
$664,700Martin L Yarmush · Massachusetts General Hospital · R01 · FY2009 · AI
Living Cell Arrays for Real Time Functional Genomics
$664,697Martin L Yarmush · Massachusetts General Hospital · R01 · FY2008 · AI
Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance
$664,531Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2024 · HL
Mass Spectrometry Quantitation
$664,399Jason Williams · National Institute Of Environmental Health Sciences · ZIC · FY2024 · ES
Deciphering Mechanisms for Triglyceride and Cholesterol Transport
$664,190Stephen G Young · University Of California Los Angeles · P01 · FY2019 · HL
Project 1: Phospholipid Remodeling in Ferroptosis and Cancer
$664,168Xuejun Jiang · Sloan-Kettering Inst Can Research · P01 · FY2025 · CA
Mechanisms of Insulin Resistance in Man
$664,154Robert A. Rizza · Mayo Clinic Rochester · R01 · FY2009 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2020 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2018 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2021 · DK
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
$664,138Ira A Tabas · Columbia University Health Sciences · R01 · FY2019 · DK